203 related articles for article (PubMed ID: 18043131)
1. Alkylphospholipids inhibit capillary-like endothelial tube formation in vitro: antiangiogenic properties of a new class of antitumor agents.
Zerp SF; Vink SR; Ruiter GA; Koolwijk P; Peters E; van der Luit AH; de Jong D; Budde M; Bartelink H; van Blitterswijk WJ; Verheij M
Anticancer Drugs; 2008 Jan; 19(1):65-75. PubMed ID: 18043131
[TBL] [Abstract][Full Text] [Related]
2. Lipid rafts and metabolic energy differentially determine uptake of anti-cancer alkylphospholipids in lymphoma versus carcinoma cells.
Vink SR; van der Luit AH; Klarenbeek JB; Verheij M; van Blitterswijk WJ
Biochem Pharmacol; 2007 Nov; 74(10):1456-65. PubMed ID: 17803969
[TBL] [Abstract][Full Text] [Related]
3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
4. Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells.
Komorowski J; Jerczyńska H; Siejka A; Barańska P; Ławnicka H; Pawłowska Z; Stepień H
Life Sci; 2006 Apr; 78(22):2558-63. PubMed ID: 16310808
[TBL] [Abstract][Full Text] [Related]
5. Bovine microvascular endothelial cells immortalized with human telomerase.
Buser R; Montesano R; Garcia I; Dupraz P; Pepper MS
J Cell Biochem; 2006 May; 98(2):267-86. PubMed ID: 16408275
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of endothelialized tube in collagen gel as starting point for self-developing capillary-like network to construct three-dimensional organs in vitro.
Takei T; Sakai S; Ono T; Ijima H; Kawakami K
Biotechnol Bioeng; 2006 Sep; 95(1):1-7. PubMed ID: 16604522
[TBL] [Abstract][Full Text] [Related]
7. TAFI and pancreatic carboxypeptidase B modulate in vitro capillary tube formation by human microvascular endothelial cells.
Guimarães AH; Laurens N; Weijers EM; Koolwijk P; van Hinsbergh VW; Rijken DC
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2157-62. PubMed ID: 17673703
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the antiangiogenic potential of AQ4N.
O'Rourke M; Ward C; Worthington J; McKenna J; Valentine A; Robson T; Hirst DG; McKeown SR
Clin Cancer Res; 2008 Mar; 14(5):1502-9. PubMed ID: 18316575
[TBL] [Abstract][Full Text] [Related]
9. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
[TBL] [Abstract][Full Text] [Related]
10. Fine-tuning of a three-dimensional microcarrier-based angiogenesis assay for the analysis of endothelial-mesenchymal cell co-cultures in fibrin and collagen gels.
Dietrich F; Lelkes PI
Angiogenesis; 2006; 9(3):111-25. PubMed ID: 17051343
[TBL] [Abstract][Full Text] [Related]
11. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices.
Saunders WB; Bayless KJ; Davis GE
J Cell Sci; 2005 May; 118(Pt 10):2325-40. PubMed ID: 15870107
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
Kong D; Okamura M; Yoshimi H; Yamori T
Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
[TBL] [Abstract][Full Text] [Related]
13. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects.
van Blitterswijk WJ; Verheij M
Curr Pharm Des; 2008; 14(21):2061-74. PubMed ID: 18691116
[TBL] [Abstract][Full Text] [Related]
14. Development of an in vitro model for vascular injury with human endothelial cells.
Schleger C; Platz SJ; Deschl U
ALTEX; 2004; 21 Suppl 3():12-9. PubMed ID: 15057404
[TBL] [Abstract][Full Text] [Related]
15. EPOX inhibits angiogenesis by degradation of Mcl-1 through ERK inactivation.
Sun HL; Tsai AC; Pan SL; Ding Q; Yamaguchi H; Lin CN; Hung MC; Teng CM
Clin Cancer Res; 2009 Aug; 15(15):4904-14. PubMed ID: 19622586
[TBL] [Abstract][Full Text] [Related]
16. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
17. Influence of angiogenesis inhibitors on endothelial cell morphology in vitro.
Friis T; Hansen AB; Houen G; Engel AM
APMIS; 2006 Mar; 114(3):211-24. PubMed ID: 16643188
[TBL] [Abstract][Full Text] [Related]
18. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.
Sieveking DP; Buckle A; Celermajer DS; Ng MK
J Am Coll Cardiol; 2008 Feb; 51(6):660-8. PubMed ID: 18261686
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.
Ng SS; Gütschow M; Weiss M; Hauschildt S; Teubert U; Hecker TK; Luzzio FA; Kruger EA; Eger K; Figg WD
Cancer Res; 2003 Jun; 63(12):3189-94. PubMed ID: 12810647
[TBL] [Abstract][Full Text] [Related]
20. Impact of alkylphospholipids on the gene expression profile of HaCaT cells.
Semini G; Klein A; Danker K
Pharmacogenet Genomics; 2011 Jul; 21(7):375-87. PubMed ID: 21681147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
